Announcements Trials

Browse Landscape

Phase

Phase NA 43 Phase 2 3 Phase 1 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 3 Breast Neoplasms 2 Thymic aplasia 1 Small Cell Lung Carcinoma 1 Pain, Postoperative 1 Neoplasms 1 Lung Neoplasms 1 Immunologic Deficiency Syndromes 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 8 Oxycodone 6 Epoetin Alfa 5 Propofol 4 Palonosetron 4 Meropenem 4 Zoledronic Acid 3 Vancomycin 3 Sevoflurane 3 Ondansetron 3 Naloxone 3 Everolimus 3 Ciprofloxacin 3 Cholecalciferol 3 Ceftazidime 3 Cefepime 3 Calcium Dobesilate 3 Bevacizumab 3 Aspirin 3 Aprepitant 3 peginterferon alfa-2a 2 edoxaban 2 apixaban 2 apatinib 2 Vitamin B 12 2 Vincristine 2 Tobacco Use Cessation Devices 2 Teicoplanin 2 Tablets 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasms × Blood Specimen Collection × Clear all

NCT02068196 2023-03-24

Ipi4

Oslo University Hospital

Phase 4 Active not recruiting

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡